【Rapid Nucleic Acid Test of Coronavirus】Cepheid has developed an automated molecular test for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19. The test can provide rapid detection of the current pandemic coronavirus SARS-CoV-2 in approximately 45 minutes with less than a minute of hands on time to prepare the sample. Cepheid’s Xpert® Xpress SARS-CoV-2 kits has received Emergency Use Authorization from US FDA. Progressive Group Inc. also has received TFDA’s Emergency USE Authorization on import of the kit on April 8, 2020.
【New Product Launch】Progressive Group Inc. launched 3M +KCI’s PREVENA Incision Management System, the first and only negative pressure medical device in the reduction of superficial surgical site infections (SSIs) in patients at a high risk for post-operative infections in wounds.
【Wound Care Collaboration】Progressive Group Inc. collaborated with Shuang Ho Hospital for comprehensive and better quality of wound care service for inpatient, outpatient and home care patients.
【Wound Care Collaboration】Tri-Service General Hospital worked with Acelity™ / KCI™ to establish the Asia Pacific Negative Pressure Wound Therapy Center not only for providing better quality of NPWT service but also serving as an institute for clinical and academic collaboration among countries in the regions.
【Education Video】NPWT – Health education